MiR-214 regulates the pathogenesis of patients with coronary artery disease by targeting VEGF

Molecular and Cellular Biochemistry

Volumn 402, Issue 1-2, 2015, Pages 111-122

  Jin, Yan ^a   Yang, Cheng Jian ^a   Xu, Xin ^a   Cao, Jia Ning ^a   Feng, Qiu Ting ^a   Yang, Jun ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Coronary artery disease (CAD); Disease marker; Endothelial progenitor cells (EPCs); MiR 214; VEGF

Indexed keywords

MICRORNA 214; TROPONIN I; VASCULOTROPIN; 3' UNTRANSLATED REGION; MICRORNA; MIRN214 MICRORNA, HUMAN; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

ACUTE HEART INFARCTION; ANGINA PECTORIS; ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD FLOW; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; DISEASE SEVERITY; ENDOTHELIAL PROGENITOR CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE REPRESSION; GENE SILENCING; GENSINI SCORE; HEART MUSCLE ISCHEMIA; HUMAN; HUMAN CELL; IN VITRO STUDY; LIMB ISCHEMIA; MAJOR CLINICAL STUDY; MOUSE; NONHUMAN; PATHOGENESIS; PROTEIN EXPRESSION; PROTEIN TARGETING; REAL TIME POLYMERASE CHAIN REACTION; 3' UNTRANSLATED REGION; ANIMAL; BINDING SITE; CASE CONTROL STUDY; CELL CULTURE; CELL PROLIFERATION; GENE EXPRESSION; GENETICS; HINDLIMB; ISCHEMIA; METABOLISM; NUDE MOUSE; PATHOLOGY; PHYSIOLOGY; RNA INTERFERENCE; VASCULARIZATION;

ANIMALIA; MUS;

3' UNTRANSLATED REGIONS; ANIMALS; BINDING SITES; CASE-CONTROL STUDIES; CELL PROLIFERATION; CELLS, CULTURED; CORONARY ARTERY DISEASE; ENDOTHELIAL PROGENITOR CELLS; GENE EXPRESSION; HINDLIMB; HUMANS; ISCHEMIA; MICE, NUDE; MICRORNAS; NEOVASCULARIZATION, PHYSIOLOGIC; RNA INTERFERENCE; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84922465151     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-014-2319-5     Document Type: Article

References (35)

1. Wang HW, Huang TS, Lo HH, Huang PH, Lin CC, Chang SJ, Liao KH, Tsai CH, Chan CH, Tsai CF, Cheng YC, Chiu YL, Tsai TN, Cheng CC, Cheng SM (2014) Deficiency of the microRNA-31-microRNA-720 pathway in the plasma and endothelial progenitor cells from patients with coronary artery disease. Arterioscler Thromb Vasc Biol 34(4):857–869
2. Bollati V, Angelici L, Rizzo G, Pergoli L, Rota F, Hoxha M, Nordio F, Bonzini M, Tarantini L, Cantone L, Pesatori AC, Apostoli P, Baccarelli AA, Bertazzi PA (2014) Microvesicle-associated microRNA expression is altered upon particulate matter exposure in healthy workers and in A549 cells. J Appl Toxicol. doi:10.1002/jat.2987. [Epub ahead of print]
3. Xiong XD, Cho M, Cai XP, Cheng J, Jing X, Cen JM, Liu X, Yang XL, Suh Y (2014) A common variant in pre-miR-146 is associated with coronary artery disease risk and its mature miRNA expression. Mutat Res, Fundam Mol Mech Mutagen 761:15–20
4. Slagsvold KH, Rognmo O, Høydal M, Wisløff U, Wahba A (2014) Remote ischemic preconditioning preserves mitochondrial function and influences myocardial microRNA expression in atrial myocardium during coronary bypass surgery. Circ Res 114(5):851–859. doi:10.1161/CIRCRESAHA.114.302751. Epub 2013 Dec 26
5. Stratz C, Nührenberg T, Fiebich BL, Amann M, Kumar A, Binder H, Hoffmann I, Valina C, Hochholzer W, Trenk D, Neumann FJ (2014) Controlled type II diabetes mellitus has no major influence on platelet micro-RNA expression. Results from micro-array profiling in a cohort of 60 patients. Thromb Haemost 111(5):902–911. doi:10.1160/TH13-06-0476. Epub 2013 Dec 19
6. D’Alessandra Y, Carena MC, Spazzafumo L, Martinelli F, Bassetti B, Devanna P, Rubino M, Marenzi G, Colombo GI, Achilli F, Maggiolini S, Capogrossi MC, Pompilio G (2013) Diagnostic potential of plasmatic microRNA signatures in stable and unstable angina. PLoS ONE 8(11):e80345. doi:10.1371/journal.pone.0080345 eCollection 2013
7. Kula D, Jadczyk T, Krajewska M, Kowalówka A, Dworowy S, Hrycek E, Włudarczyk W, Parma Z, Tendera M, Wojakowski W (2013) Circulating microRNAs (miR-423-5p, miR-208a and miR-1) in acute myocardial infarction and stable coronary heart disease. Minerva Cardioangiol 61(6):627–637
8. Vickers KC, Moore KJ (2013) Small RNA overcomes the challenges of therapeutic targeting of microsomal triglyceride transfer protein. Circ Res 113(11):1189–1191
9. Sun X, He S, Wara AK, Icli B, Shvartz E, Tesmenitsky Y, Belkin N, Li D, Blackwell TS, Sukhova GK, Croce K, Feinberg MW (2014) Systemic delivery of microRNA-181b inhibits nuclear factor-κB activation, vascular inflammation, and atherosclerosis in apolipoprotein E-deficient mice. Circ Res 114(1):32–40
10. Wang F, Long G, Zhao C, Li H, Chaugai S, Wang Y, Chen C, Wang DW (2013) Plasma microRNA-133a is a new marker for both acute myocardial infarction and underlying coronary artery stenosis. J Transl Med 23(11):222
11. Lu HQ, Liang C, He ZQ, Fan M, Wu ZG (2013) Circulating miR-214 is associated with the severity of coronary artery disease. J Geriatr Cardiol 10(1):34–38. doi:10.3969/j.issn.1671-5411.2013.01.007
12. Jansen F, Yang X, Hoelscher M, Cattelan A, Schmitz T, Proebsting S, Wenzel D, Vosen S, Franklin BS, Fleischmann BK, Nickenig G, Werner N (2013) Endothelial microparticle-mediated transfer of MicroRNA-126 promotes vascular endothelial cell repair via SPRED1 and is abrogated in glucose-damaged endothelial microparticles. Circulation 128(18):2026–2038
13. Tousoulis D, Papageorgiou N, Androulakis E, Siasos G, Latsios G, Tentolouris K, Stefanadis C (2013) Diabetes mellitus-associated vascular impairment: novel circulating biomarkers and therapeutic approaches. J Am Coll Cardiol 62(8):667–676. doi:10.1016/j.jacc.2013.03.089
14. Liao XB, Zhang ZY, Yuan K, Liu Y, Feng X, Cui RR, Hu YR, Yuan ZS, Gu L, Li SJ, Mao DA, Lu Q, Zhou XM, de Jesus Perez VA, Yuan LQ (2013) MiR-214 modulates osteogenic differentiation of vascular smooth muscle cells. Endocrinology 154(9):3344–3352. doi:10.1210/en.2012-2236. Epub 2013 Jun 24
15. Danowski N, Manthey I, Jakob HG, Siffert W, Peters J, Frey UH (2013) Decreased expression of miR-214 but not of miR-1 is associated with signs of heart failure in patients undergoing coronary bypass surgery. Cardiology 125(2):125–130. doi:10.1159/000348563. Epub 2013 May 24
16. Coleman CB, Lightell DJ Jr, Moss SC, Bates M, Parrino PE, Woods TC (2013) Elevation of miR-221 and -222 in the internal mammary arteries of diabetic subjects and normalization with metformin. Mol Cell Endocrinol 374(1-2):125–129. doi:10.1016/j.mce.2013.04.019. Epub 2013 May 3
17. Huang F, Li ML, Fang ZF, Hu XQ, Liu QM, Liu ZJ, Tang L, Zhao YS, Zhou SH (2013) Overexpression of microRNA-1 improves the efficacy of mesenchymal stem cell transplantation after myocardial infarction. Cardiology 125(1):18–30. doi:10.1159/000347081. Epub 2013 Apr 20
18. Wagner J, Riwanto M, Besler C, Knau A, Fichtlscherer S, Röxe T, Zeiher AM, Landmesser U, Dimmeler S (2013) Characterization of levels and cellular transfer of circulating lipoprotein-bound microRNAs. Arterioscler Thromb Vasc Biol 33(6):1392–1400
19. Tomé-Carneiro J, Larrosa M, Yáñez-Gascón MJ, Dávalos A, Gil-Zamorano J, Gonzálvez M, García-Almagro FJ, Ruiz Ros JA, Tomás-Barberán FA, Espín JC, García-Conesa MT (2013) One-year supplementation with a grape extract containing resveratrol modulates inflammatory-related microRNAs and cytokines expression in peripheral blood mononuclear cells of type 2 diabetes and hypertensive patients with coronary artery disease. Pharmacol Res 72:69–82. doi:10.1016/j.phrs.2013.03.011. Epub 2013 Apr 1
20. Wang J, Yan CH, Li Y, Xu K, Tian XX, Peng CF, Tao J, Sun MY, Han YL (2013) MicroRNA-31 controls phenotypic modulation of human vascular smooth muscle cells by regulating its target gene cellular repressor of E1A-stimulated genes. Exp Cell Res 319(8):1165–1175. doi:10.1016/j.yexcr.2013.03.010. Epub 2013 Mar 19
21. Hutcheson R, Terry R, Chaplin J, Smith E, Musiyenko A, Russell JC, Lincoln T, Rocic P (2013) MicroRNA-145 restores contractile vascular smooth muscle phenotype and coronary collateral growth in the metabolic syndrome. Arterioscler Thromb Vasc Biol 33(4):727–736
22. Zhang X, Mao H, Chen JY, Wen S, Li D, Ye M, Lv Z (2013) Increased expression of microRNA-221 inhibits PAK1 in endothelial progenitor cells and impairs its function via c-Raf/MEK/ERK pathway. Biochem Biophys Res Commun 431(3):404–408. doi:10.1016/j.bbrc.2012.12.157. Epub 2013 Jan 16
23. Balderman JA, Lee HY, Mahoney CE, DE Handy, White K, Annis S, Lebeche D, Hajjar RJ, Loscalzo J, Leopold JA (2012) Bone morphogenetic protein-2 decreases microRNA-30b and microRNA-30c to promote vascular smooth muscle cell calcification. J Am Heart Assoc 1(6):e003905. doi:10.1161/JAHA.112.003905. Epub 2012 Dec 19
24. Kin K, Miyagawa S, Fukushima S, Shirakawa Y, Torikai K, Shimamura K, Daimon T, Kawahara Y, Kuratani T, Sawa Y (2012) Tissue- and plasma-specific microRNA signatures for atherosclerotic abdominal aortic aneurysm. J Am Heart Assoc 1(5):e000745
25. Zhu J, Chen T, Yang L, Li Z, Wong MM, Zheng X, Pan X, Zhang L, Yan H (2012) Regulation of microRNA-155 in atherosclerotic inflammatory responses by targeting MAP3K10. PLoS ONE 7(11):e46551
26. Barjaktarovic Z, Anastasov N, Azimzadeh O, Sriharshan A, Sarioglu H, Ueffing M, Tammio H, Hakanen A, Leszczynski D, Atkinson MJ, Tapio S (2013) Integrative proteomic and microRNA analysis of primary human coronary artery endothelial cells exposed to low-dose gamma radiation. Radiat Environ Biophys 52(1):87–98. doi:10.1007/s00411-012-0439-4. Epub 2012 Nov 9
27. Greliche N, Zeller T, Wild PS, Rotival M, Schillert A, Ziegler A, Deloukas P, Erdmann J, Hengstenberg C, Ouwehand WH, Samani NJ, Schunkert H, Munzel T, Lackner KJ, Cambien F, Goodall AH, Tiret L, Blankenberg S, Trégouët DA, Cardiogenics Consortium (2012) Comprehensive exploration of the effects of miRNA SNPs on monocyte gene expression. PLoS ONE 7(9):e45863
28. Sun X, Zhang M, Sanagawa A, Mori C, Ito S, Iwaki S, Satoh H, Fujii S (2012) Circulating microRNA-126 in patients with coronary artery disease: correlation with LDL cholesterol. Thromb J. 10(1):16. doi:10.1186/1477-9560-10-16
29. Cardin S, Guasch E, Luo X, Naud P, Le Quang K, Shi Y, Tardif JC, Comtois P, Nattel S (2012) Role for microRNA-21 in atrial profibrillatory fibrotic remodeling associated with experimental postinfarction heart failure. Circ Arrhythm Electrophysiol 5(5):1027–1035. doi:10.1161/CIRCEP.112.973214. Epub 2012 Aug 26
30. Pan Z, Sun X, Shan H, Wang N, Wang J, Ren J, Feng S, Xie L, Lu C, Yuan Y, Zhang Y, Wang Y, Lu Y, Yang B (2012) MicroRNA-101 inhibited postinfarct cardiac fibrosis and improved left ventricular compliance via the FBJ osteosarcoma oncogene/transforming growth factor-β1 pathway. Circulation 126(7):840–850. doi:10.1161/CIRCULATIONAHA.112.094524. Epub 2012 Jul 18
31. Gao W, He HW, Wang ZM, Zhao H, Lian XQ, Wang YS, Zhu J, Yan JJ, Zhang DG, Yang ZJ, Wang LS (2012) Plasma levels of lipometabolism-related miR-122 and miR-370 are increased in patients with hyperlipidemia and associated with coronary artery disease. Lipids Health Dis 15(11):55. doi:10.1186/1476-511X-11-55
32. Hulsmans M, Sinnaeve P, Van der Schueren B, Mathieu C, Janssens S, Holvoet P (2012) Decreased miR-181a expression in monocytes of obese patients is associated with the occurrence of metabolic syndrome and coronary artery disease. J Clin Endocrinol Metab 97(7):E1213–E1218. doi:10.1210/jc.2012-1008. Epub 2012 Apr 24
33. Tabuchi T, Satoh M, Itoh T, Nakamura M (2012) MicroRNA-34a regulates the longevity-associated protein SIRT1 in coronary artery disease: effect of statins on SIRT1 and microRNA-34a expression. Clin Sci (Lond) 123(3):161–171
34. Vavuranakis M, Kariori M, Vrachatis D, Aznaouridis K, Siasos G, Kokkou E, Mazaris S, Moldovan C, Kalogeras K, Tousoulis D, Stefanadis C (2013) MicroRNAs in aortic disease. Curr Top Med Chem 13(13):1559–1572
35. Eskildsen TV, Jeppesen PL, Schneider M, Nossent AY, Sandberg MB, Hansen PB, Jensen CH, Hansen ML, Marcussen N, Rasmussen LM, Bie P, Andersen DC, Sheikh SP (2013) Angiotensin II Regulates microRNA-132/-212 in Hypertensive Rats and Humans. Int J Mol Sci 14(6):11190–11207. doi:10.3390/ijms140611190